Status:
SUSPENDED
Total Cerebral Protection With Embolic Protection Devices Thoracic Aortic Stenting
Lead Sponsor:
Imperial College London
Collaborating Sponsors:
St Mary's Hospital, London
Conditions:
Stroke
Silent Cerebral Infarct
Eligibility:
All Genders
Brief Summary
Stroke and silent cerebral infarction are a real risk with thoracic enodvascular aortic repair (TEVAR). The investigator propose to prospectively observational study with enrolment of all patients und...
Detailed Description
TEVAR involves the insertion of a stent into the thoracic aorta to re-line it and prevent life-threatening haemorrhage from rupture, and ultimately death. The stent is inserted through a small cut in ...
Eligibility Criteria
Inclusion
- All patients requiring TEVAR as decided upon by a multidisciplinary meeting
Exclusion
- Contraindication to MRI scanning
- Unable to give consent
Key Trial Info
Start Date :
October 4 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2021
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04062539
Start Date
October 4 2018
End Date
November 1 2021
Last Update
August 22 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St Mary's Hospital
London, United Kingdom, W21NY